Inventor · disambiguated record
Eric Hryhorenko
Also filed as: HRYHORENKO ERIC
36 granted patents·7 pending applications·257 citations·filing 2005–2020
97Inventor score
Files withJANSSEN PHARMACEUTICA NV37ORTHO CLINICAL DIAGNOSTICS INC4ELAN PHARM INC1SALADAX BIOMEDICAL INC1
Top patents by PatentIndex Score
43 records- 0196US9611332B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 4, 2017·18 cites·7 claims
- 0296US9494607B2Antibodies to aripiprazole and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·17 cites·23 claims
- 0396US9465041B2Antibodies to paliperidone and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Oct 11, 2016·22 cites·18 claims
- 0495US9795685B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 24, 2017·17 cites·44 claims
- 0595US9410972B2Antibodies to quetiapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Aug 9, 2016·17 cites·20 claims
- 0695US9394354B2Haptens of paliperidoneJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 19, 2016·18 cites·3 claims
- 0795US9012648B2Haptens of risperidone and paliperidoneJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 21, 2015·21 cites·18 claims
- 0894US9664700B2Antibodies to risperidone and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 30, 2017·19 cites·27 claims
- 0994US9494608B2Antibodies to olanzapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·15 cites·25 claims
- 1093US9751953B2Antibodies to risperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Sep 5, 2017·18 cites·8 claims
- 1192US9850318B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 26, 2017·16 cites·15 claims
- 1292US9504682B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 29, 2016·17 cites·13 claims
- 1391US9303041B2Haptens of olanzapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·29 claims
- 1491US9304126B2Haptens of quetiapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·21 claims
- 1582US10690686B2Antibodies to risperidone and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 23, 2020·2 cites·32 claims
- 1681US10793644B2Antibodies to risperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 6, 2020·2 cites·25 claims
- 1780US10852313B2Antibodies to risperidone and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 1, 2020·1 cites·20 claims
- 1879US10379129B2Antibodies to paliperidone and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 13, 2019·1 cites·11 claims
- 1978US10175257B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 8, 2019·1 cites·19 claims
- 2076US10444250B2Antibodies to risperidone and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 15, 2019·1 cites·22 claims
- 2173US11385246B2Antibodies to paliperidone and use thereofSALADAX BIOMEDICAL INC·Filed 2019·Granted Jul 12, 2022·0 cites·11 claims
- 2272US11105793B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·11 claims
- 2371US11046786B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 29, 2021·0 cites·20 claims
- 2471US10816561B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 27, 2020·0 cites·26 claims
- 2570US2020399400A1Antibodies to risperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2670US2021017294A9Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2769US2019271712A1Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2868US11225527B2Antibodies to paliperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 18, 2022·0 cites·11 claims
- 2966US10488401B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 26, 2019·0 cites·15 claims
- 3064US10712353B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 14, 2020·0 cites·7 claims
- 3163US11104742B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·21 claims
- 3263US10379105B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 13, 2019·0 cites·8 claims
- 3362US11226345B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 18, 2022·0 cites·15 claims
- 3460US10370457B2Antibodies to paliperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 6, 2019·0 cites·8 claims
- 3560US2014057297A1Antibodies to Paliperidone Haptens and Use ThereofJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3659US10465013B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 5, 2019·0 cites·14 claims
- 3759US10288631B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 14, 2019·0 cites·12 claims
- 3859US10166296B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 1, 2019·0 cites·9 claims
- 3958US10344098B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 9, 2019·0 cites·25 claims
- 4057US10435478B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 8, 2019·0 cites·25 claims
- 4157US2017298147A1Antibodies to paliperidone haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 4256US2014057303A1Antibodies to Olanzapine Haptens and Use ThereofJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 4342US2006160161A1Methods for assessing antibodies to neurodegenerative disease-associated antigensELAN PHARM INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Hryhorenko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →